DavidBruceKudrowMD
Neurology • Century City, CAHeadache
Director, California Medical Clinic for Headache. Director, Headache Clinic Harbor-UCLA Medical Center. Assistant Clinical Professor in Neurology UCLA David Geffen School of Medicine.
Dr. Kudrow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2080 Century Park East
Suite 805
Century City, CA 90067Phone+1 310-315-1456Fax+1 310-315-1486- Is this information wrong?
Summary
- Dr. David Kudrow is a neurologist in Century City, CA and is affiliated with Providence Saint John's Health Center. He received his medical degree from University of Southern California School of Medicine and has been in practice 35 years. He specializes in headache and is experienced in migraine disorders and headache disorders.
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterResidency, Neurology, 1987 - 1991
UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1986 - 1987
Keck School of Medicine of the University of Southern CaliforniaClass of 1986
Certifications & Licensure
MT State Medical License 2020 - 2026
IL State Medical License 2019 - 2026
TX State Medical License 2020 - 2026
UT State Medical License 2019 - 2026
FL State Medical License 2019 - 2025
WA State Medical License 2020 - 2025
CA State Medical License 1988 - 2025- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine. Start of enrollment: 2005 Dec 01
- Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine Start of enrollment: 2008 Apr 01
- Preventive Treatment of Episodic and Chronic Migraine Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsLong-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.Stewart J Tepper, Richard B Lipton, Stephen D Silberstein, David Kudrow, Messoud Ashina, Uwe Reuter, David W Dodick, Andrea Wang, Sunfa Cheng, Jan Klatt, Daniel D Mikol> ;Headache. 2023 Jun 1
- 3 citationsEvaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data.David Kudrow, Rima Dafer, David W Dodick, Amaal Starling, Jessica Ailani, Carrie Dougherty, Kavita Kalidas, Feng Zhang, Rohini Jeswani, Nishil Patel, Ani C Khodavirdi> ;Headache. 2023 Mar 1
- 6 citationsA phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene-related peptide ligand (galcane...David Kudrow, Linda Nguyen, Jack Semler, Chad Stroud, Karen Samaan, Deirdre B Hoban, Linda Wietecha, Hai-An Hsu, Eric Pearlman> ;Headache. 2022 Oct 1
- Join now to see all
Press Mentions
- Long-Term Safety and Tolerability of Eptinezumab in Patients with Chronic Migraine: A 2-Year, Open-Label, Phase 3 TrialMarch 19th, 2021
FDA Approves Galcanezumab-Gnlm for Episodic Cluster HeadacheJune 5th, 2019
Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual MeetingApril 23rd, 2019- Join now to see all
Hospital Affiliations
Providence Saint John's Health CenterSanta Monica, California
Los Robles Health SystemThousand Oaks, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
